Rajputana Invest (539090)
CyclicalScore breakdown: P/E: 0/3 · ROCE: 1/2 · Growth: 0/2 · Dividend: 0/1
Key Financials
| Current Price | ₹33.95 |
| Market Cap | ₹10.46 Cr |
| P/E Ratio | 84.67 |
| ROCE | 12.89% |
| ROE | 3.16% |
| Dividend Yield | 0% |
| Profit Growth | -83.33% |
| Debt/Equity | — |
| Sales Growth | -64.06% |
| 52-Week Range | ₹30.02 — ₹46.8 |
| Sector | Finance |
| Book Value | ₹12.99 |
Strengths
- ROCE of 12.89% suggests decent operational efficiency, at least on a historical basis.
- Book value per share of ₹12.99 provides a tangible asset cushion, though small.
- Remains marginally profitable on a trailing basis despite the slump.
- Trades near the lower end of its 52-week range, offering a potential entry point if fundamentals stabilize.
Concerns
- Sales down 64.06% and profit down 83.33% indicate a severe business contraction.
- P/E of 84.67 and P/B of 2.61 are expensive given the 3.16% ROE and zero dividend yield.
- Piotroski F-Score of 3/9 reflects weak financial health and poor operating efficiency.
- Promoter holding not disclosed, raising governance and transparency concerns.
AI Analysis
At ₹33.95, this tiny NBFC, Rajputana Invest, commands a market cap of just ₹10 Cr. The first thing that strikes me is the contradiction between price and fundamentals. I am being asked to pay 2.61 times book value, yet the business earns a paltry 3.16% ROE. Graham would balk. A company producing ₹1 Cr in quarterly sales and essentially zero net profit cannot justify a P/E of 84.67. Sales have collapsed by 64% and profit by 83%, with a Piotroski F-Score of 3/9 confirming serious deterioration. There is no moat here—no pricing power, no scale, no brand. The ROCE of 12.89% looks respectable, but with revenue shrinking, that may fade quickly. The 52-week range of ₹30.02 to ₹49.80 shows the market itself is confused. As value investors, we don't buy because the price has fallen; we buy because the business is worth more than the price. Here, the asset base is thin, earning power is weak, and there is no dividend to compensate me while I wait. Promoter holding is undisclosed, leaving a transparency gap I cannot ignore. This is not a wonderful business at a fair price; it is a mediocre business at an expensive price. I would keep it on my watchlist, not in my portfolio.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer